...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Value

NBB,

Wish I could help shed some light. But I, like you and most other shareholders have been left in the dark for over 8 months now since the December 2016 AGM. Very little has been revealed in 2017 and I feel that we are long overdue for an update. But Zenith is a private company..........

BearDownAZ

Share
New Message
Please login to post a reply